Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Melike Ozcelik

Erratum To: Single-Agent Bevacizumab Is an Effective Treatment in Recurrent Glioblastoma

Medical Oncology

Cancer Research

English

Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas

Balkan Medical Journal

English

Related publications

Bevacizumab and Chemotherapy for Recurrent Glioblastoma: A Single-Institution Experience

English

Bevacizumab in the Treatment of Glioblastoma: Is There an Optimal Dose or Schedule?

English

Sustained Focal Antitumor Activity of Bevacizumab in Recurrent Glioblastoma

English

Addition of Lomustine for Bevacizumab-Refractory Recurrent Glioblastoma

Acta Oncologica

Nuclear Medicine

English

Single-Institution Retrospective Review of Patients With Recurrent Glioblastoma Treated With Bevacizumab in Clinical Practice

Health Science Reports

English

Tumor Cell Response to Bevacizumab Single Agent Therapy in Vitro

Cancer Cell International

Cancer Research

English

Antiangiogenic Agents in the Treatment of Recurrent or Newly Diagnosed Glioblastoma: Analysis of Single-Agent and Combined Modality Approaches

Radiation Oncology

Nuclear Medicine

English

Angiotensinogen and HLA Class II Predict Bevacizumab Response in Recurrent Glioblastoma Patients

Molecular Oncology

Cancer Research

Molecular Medicine

English

Single Agent Therapy With Bevacizumab for the Treatment of Atypical Choroid Plexus Tumor

Kansas Journal of Medicine

English